If Amplitude was sitting on a watchlist rather than in your portfolio, the recent share move may feel like a missed shot. Holding Amplitude from the start of the year would have returned 56.3%, including dividends. That is a strong payoff for a business that spent much of the year juggling AI investment, profit pressure and even a securities investigation. The question is simple. What early assumption about enterprise adoption and AI analytics could have helped you spot this setup before it played out?
Narratives are how investors here put a case on the record, with explicit assumptions about revenue, margins and the multiple. Those assumptions imply an estimated Fair Value.
Amplitude is not the only name tied to this theme. Zero in on 39 AI small caps and compare how each one is priced.
The shares cost US$11.58 at the start of the period, which required investors to consider what kind of future Amplitude might earn from AI analytics and enterprise demand.
On the optimistic side, the bull narrative put fair value at US$15.67, or 35% above the start price. It was based on an assumption of 13.8% annual revenue growth, supported by enterprise adoption and AI-driven analytics that could justify premium pricing.
The bear narrative set fair value at US$11, or 5% below the start price. That view assumed 10.3% annual revenue growth and focused on regulatory pressure and privacy rules that could restrict access to user data.
The most concrete evidence for Amplitude was the Q2 2026 report. Revenue reached US$100.89m compared with US$83.27m a year earlier, which lent some support to the optimistic demand story. Profit told a different tale. The firm reported a larger loss of US$34.62m and net margin fell from 29.6% to 34.3%. Overall, the new data cut both ways.
The key lesson is simple. When an AI narrative leans on future profitability, track whether losses shrink and net margin moves toward the promised level, even as spending on new products rises.
Amplitude now trades at US$17.08, well above the level at the start of the year. The selected Narrative places its Fair Value below that mark, arguing that the market could be giving generous credit for the AI transition, contract structure and data usage trends.
For that to hold up, a buyer needs to believe Amplitude can keep lifting ARR quality and operating leverage even if AI-heavy products keep gross margins in the low 70s. The specific test is whether enterprise and AI-native customers keep signing richer, longer contracts that outweigh sustained inference and integration costs.
"Although Amplitude is leaning into an AI native product shift, management now expects gross margins to stay in the low 70s as higher inference costs and heavier data ingestion become structural. This could keep non GAAP operating margins well below long term targets and cap future earnings growth. While the Statsig partnership adds warehouse native experimentation and feature management that could expand Amplitude’s reach into data leader and AI focused budgets, the low 50s gross margin profile and added R&D and transition spend create a risk that future revenue growth will be less accretive to net income than current expectations assume."
The price and this Narrative do not agree. → Uncover what this Narrative says Amplitude is actually worth
What if your next investment idea came before the headlines? Go straight to the companies whose prices and our estimates still disagree. Three places to start, with the names waiting behind the link.
That is three of the list. See the full list of 33 companies trading below our fair value estimates →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com